文献速递前列腺癌

主动监测中连续MRI变化与前列腺癌病理进展的关联

Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance.
PubMed 文献 · Eur Urol Oncol · 2020-10-21

研究纳入391例主动监测患者,共621个MRI间隔按PRECISE标准评分并以活检验证;稳定MRI对GG1进展至GG3的阴性预测值为0.94,若仅对MRI阳性者行2年活检,3.7%的避免活检会漏诊进展,PSA密度是稳定MRI下进展的风险因素。

要点

  • 稳定MRI(PRECISE<4)对GG1进展至GG3的阴性预测值为0.94。
  • 仅按MRI阳性决定2年活检,3.7%避免的活检会漏诊GG1至GG3进展。
  • PSA密度是稳定MRI下GG1进展至GG3的风险因素(OR 1.95)。

核心结论

  • GG1患者稳定MRI(PRECISE评分<4)时进展至GG3不常见。
  • 稳定MRI但活检发现分级进展者,PSA密度升高是进展至GG3的风险因素。

研究设计与样本

  • 2007年7月至2020年1月单机构主动监测患者,确认活检后共391例至少一次监测MRI和活检,中位随访35.6个月(IQR 19.7-60.6)。
  • 所有MRI间隔按PRECISE标准评分,PRECISE≥4定义为MRI阳性变化。
  • 对PRECISE<4的间隔用广义估计方程logistic回归分析稳定MRI下Gleason分级组进展的预测因素。

主要发现

  • 共621个MRI间隔经PRECISE评分并由活检验证。
  • 稳定MRI(PRECISE<4)检测GG1进展至GG3的阴性预测值最高,为0.94(95%CI 0.91-0.97)。
  • 若仅对MRI阳性变化者行2年监测活检,3.7%(4/109)被避免的活检会漏诊GG1至GG3进展。
  • PSA密度是稳定MRI下GG1进展至GG3的风险因素(OR 1.95,95%CI 1.17-3.25,P=0.01)。

关键数值与推荐

  • PRECISE评分≥4视为MRI阳性变化。
  • 稳定MRI对GG1至GG3进展的阴性预测值为0.94(95%CI 0.91-0.97)。
  • 仅按MRI阳性行2年活检时,3.7%(4/109)避免的活检会漏诊GG1至GG3进展。
  • PSA密度预测稳定MRI下GG1至GG3进展的OR为1.95(95%CI 1.17-3.25,P=0.01)。

临床怎么用

  • GG1主动监测患者MRI稳定(PRECISE<4)时,进展至GG3的风险较低。
  • PSA密度升高的患者即使MRI稳定,仍应警惕分级进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ability of serial magnetic resonance imaging (MRI) to capture pathologic progression during active surveillance (AS) remains in question. OBJECTIVE: To determine whether changes in MRI are associated with pathologic progression for patients on AS. DESIGN, SETTING, AND PARTICIPANTS: From July 2007 through January 2020, we identified all patients evaluated for AS at our institution. Following confirmatory biopsy, a total of 391 patients who underwent surveillance MRI and biopsy at least once were identified (median follow-up of 35.6 mo, interquartile range 19.7-60.6). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: All MRI intervals were scored using the "Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation" (PRECISE) criteria, with PRECISE scores =4 considered a positive change in MRI. A generalized estimating equation-based logistic regression analysis was conducted for all intervals with a PRECISE score of <4 to determine the predictors of Gleason grade group (GG) progression despite stable MRI. RESULTS AND LIMITATIONS: A total of 621 MRI intervals were scored by PRECISE and validated by biopsy. The negative predictive value of stable MRI (PRECISE score <4) was greatest for detecting GG1 to?=?GG3 disease (0.94 [0.91-0.97]). If 2-yr surveillance biopsy were performed exclusively for a positive change in MRI, 3.7% (4/109) of avoided biopsies would have resulted in missed progression from GG1 to?=?GG3 disease. Prostate-specific antigen (PSA) density (odds ratio 1.95 [1.17-3.25], p?=? 0.01) was a risk factor for progression from GG1 to =GG3 disease despite stable MRI. CONCLUSIONS: In patients with GG1 disease and stable MRI (PRECISE score <4) on surveillance, grade progression to?=?GG3 disease is not common. In patients with grade progression detected on biopsy despite stable MRI, elevated PSA density appeared to be a risk factor for progression to?=?GG3 disease. PATIENT SUMMARY: For patients with low-risk prostate cancer on active surveillance, the risk of progressing to grade group 3 disease is low with a stable magnetic resonance image (MRI) after 2?yr. Having higher prostate-specific antigen density increases the risk of progression, despite having a stable MRI.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. O'Connor LP, Wang AZ, Yerram NK, et al. Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance. Eur Urol Oncol. 2020. PMID: 33867045. doi:10.1016/j.euo.2020.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。